It is a Medical Education Program Sub-specialized in Clinical Pathology, consists of 4 semesters of study periods and 78 study load credits. This program is consist of five sub-specialized program including Haematology, Microbiology and Infectious Disease, Immunology, Endocrine and Metabolic Disease, Gastroenterohepatology, Nephrology and Respiration.
Clinical Pathology subspecialty program uses cutting-edge technology including Immunophenotyping, NGS (Next Generation Sequencing), GSP (Genetic Screening Processor), PCR (Polymerized Chain Reaction), Flowcytometry, Digital Imaging, HPLC (High Performance Liquid Chromatography), Teaching Microscope, Robust Chemistry Analyzer. Furthermore, the teachers are experts in their particular sub-specialties.
The Clinical Pathology Sub-specialized Study Program vision is consistent with the mission of Universitas Airlangga, particularly the Faculty of Medicine. The Clinical Pathology Sub-specialized Study Program aspires to be an independent, innovative, and leading center of Clinical Pathology Sub-specialized Study Program on a national and international scale, as well as a pioneer in the development of science, technology, humanities, entrepreneurship, and the arts based on religious morals.
1.) Organizing and developing academic and professional education for clinical pathology specialist doctors based on national values and religious morality, with world-class excellence and cutting-edge learning technologies.
2.) Conduct world-class basic, applied, and policy research based on national values and religious morality to assist the development of education and community service through publications and presentations at the national and international levels.
3.) Devoting knowledge in science and medical technology to Clinical Pathology Consultants with an entrepreneurial spirit and humanities for public health
4.) Manage study programs independently with excellent governance through quality-oriented institutional growth capable of competing at the world level.
5.) Improving competent Clinical Pathology Sub-specialized graduates’ moral and ethical principles
6.) Establishing a professional network between clinical medical research and basic medical knowledge within a single team effort Developing moral and ethical principles in capable Clinical Pathology Sub-specialized graduates
Graduates of the Clinical Pathology Sub-specialized at UNAIR Surabaya’s Faculty of Medicine are anticipated to have a career as a professional clinical laboratory consultant, a good teacher, a creative researcher, and an entrepreneur.
1.) Generally Goals
The overall goal of the Clinical Pathology Sub-specialized educational program is to produce Clinical Pathology Sub-specialized Doctors who meet the competency standards of Clinical Pathology Sub-specialized doctors in the specific field and are capable of improving education, research, and Laboratory Medicine service in Indonesia.
2.) Specific Goals
1. Professional Clinical Laboratory Consultant
Able to provide professional consultation in laboratory services such as screening, diagnosis, monitoring therapy, and disease prognosis.
2.) Excellent Teacher
Conduct continuing education and training initiatives in the field of Clinical Pathology for the community.
3.) Innovative Researcher
Doctors Sp2 in Clinical Pathology capable of developing basic, transitional, clinical, and epidemiological research.
that can operate laboratory institutes or institutions on their own so that they can continue to develop and compete.
– Clinical Hematology sub-specialty : Subsp. H.K (K)
– Clinical Immunology Sub-specialist : Subsp. I.K (K)
– Infectious Disease Sub-specialist : Subsp. P.I (K)
– Endocrinology and Metabolism sub-specialist : Subsp. E.M (K)
– Gastroenterohepatology sub-specialty : Subsp. G.E.H (K)
– Nephrology and Respiration Sub-specialist : Subsp. N.R (K)
On campus, General Academic Dr. Soetomo Hospital, and other hospitals
Twice a year, every July and February
2 years (4 semesters)
National : Collegium and LAM PT-Kes (Lembaga Akreditasi Mandiri Pendidikan Tinggi Kesehatan Indonesia) ongoing process.